Presentation TCT 2012

Benefits of CD 34 Antibody Coated Stent in Patients with High Risk for Bleeding During Dual Antiplatelet Therapy.

Presenter: Miltiadis Papalexandris, Hubertus Degen, Carsten Stoepel, Thomas Lickfeld, Thorsten Schneider, Carlos Freitas, Michael Haude

January 03, 2012

REGISTER for free or LOG IN to view this content

Benefits of CD 34 Antibody Coated Stent in Patients with High Risk for Bleeding During Dual Antiplatelet Therapy.

CAD Pharma

Presentation

TCT 2012

Up Next

Presentation TCT 2013

Timing of Intervention in Asymptomatic MR

Presenter: Maurice Sarano

October 30, 2013

More slides +

Presentation TCT 2013

Drug-Coated Balloon Mechanisms of Action: A Transparent Review of What We Don't Know

Presenter: Robert Schwartz

October 31, 2013

Presentation TCT 2013

Basics of Transradial Access: A Video Tutorial

Presenter: Robert Applegate

October 31, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.